期刊文献+

2型糖尿病患者血清护骨素与颈动脉内膜中层厚度的相关性 被引量:2

下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血清护骨素(OPG)与颈动脉内膜-中层厚度的相关性。方法选取2型糖尿病患者102例作为病例组(T2DM组),40例同期健康志愿者为对照组(NC组)。应用彩色高频多普勒超声诊断仪检测患者颈动脉内膜中层厚度(IMT),以ELISA法检测血浆血清OPG含量。结果与NC组相比,T2DM组体重指数(BMI)、腰臀比(WHR)、空腹血糖(FPG)、糖化血红蛋白(Hb A1c)、胰岛素抵抗指数(HOMAIR)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、IMT及血清OPG水平均升高(P<0.05);两组颈动脉IMT与血清OPG均有相关性。T2DM组血清OPG与IMT、FPG、Hb A1c、HOMA-IR具有线性关系,多元逐步回归分析显示,IMT与年龄、收缩压(SBP)、血清OPG呈线性回归关系。结论年龄、(SBP)与血清OPG是影响T2DM患者颈动脉内膜中层的相关因素。
出处 《中国老年学杂志》 CAS 北大核心 2017年第6期1376-1378,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献5

二级参考文献18

  • 1向光大,孙慧伶,赵林双,侯洁,乐岭,徐琳.1型糖尿病患者胰岛素治疗前后血浆护骨素的变化[J].中华医学杂志,2007,87(18):1234-1237. 被引量:32
  • 2Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density.Cell,1997,89:309-319.
  • 3Venuraju SM,Yerramasu A,Corder R,et al.Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity.J Am Coil Cardiol,2010,55:2049-2061.
  • 4Br(o)ndstr(o)m H,Stiger F,Lind L,et al.A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function.Biochem Biophys Res Commun,2002,293:13-17.
  • 5Anand DV,Lahiri A,Lim E,et al.The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.Am Coll Cardiol,2006,47:1850-1857.
  • 6Rhee EJ,Yun EJ,Oh KW,et al.The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)gene polymorphism and aortic calcification in Korean women.Endocr J,2010,57:541-549.
  • 7Ohmori R,Momiyama Y,Taniguchi H,et al.Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men.Atherosclerosis,2006,187:215-217.
  • 8刘长青,许丹,卢峰,纪征,姜玉凤,张春来,孙淑娴.冠心病合并糖尿病患者冠状动脉造影分析[J].中国动脉硬化杂志,2007,15(5):389-391. 被引量:4
  • 9Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early cruet osteoporosis and arterial calcification [J]. Genes Dev, 1998, 12 (9) : 1 260-268.
  • 10Min H, Morony S, Serosi I, et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a proceas resembling osteoclastogenesis [J]. J Exp Med, 2000, 192 (4): 463-474.

共引文献37

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部